Clinical Pharmacokinetics

Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease
pp. 1-11(11)
Authors: Bramer S.L.; Forbes W.P.; Mallikaarjun S.

Relative Bioavailability and Effects of a High Fat Meal on Single Dose Cilostazol Pharmacokinetics
pp. 13-23(11)
Authors: Bramer S.L.; Forbes W.P.

Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cilostazol
pp. 25-32(8)
Authors: Bramer S.L.; Forbes W.P.

Effect of Renal Impairment on the Pharmacokinetics of Cilostazol and its Metabolites
pp. 33-40(8)
Authors: Mallikaarjun S.; Forbes W.P.; Bramer S.L.

Inhibition of CYP2D6 by Quinidine and its Effects on the Metabolism of Cilostazol
pp. 41-51(11)
Authors: Bramer S.L.; Suri A.

Effect of Omeprazole on the Metabolism of Cilostazol
pp. 53-59(7)
Authors: Suri A.; Bramer S.L.

Effects of CYP3A Inhibition on the Metabolism of Cilostazol
pp. 61-68(8)
Authors: Suri A.; Forbes W.P.; Bramer S.L.

Effect of Multiple Cilostazol Doses on Single Dose Lovastatin Pharmacokinetics in Healthy Volunteers
pp. 69-77(9)
Authors: Bramer S.L.; Brisson J.; Corey A.E.; Mallikaarjun S.

Effect of Cilostazol on the Pharmacokinetics and Pharmacodynamics of Warfarin
pp. 79-86(8)
Authors: Mallikaarjun S.; Bramer S.L.

Interaction Potential and Tolerability of the Coadministration of Cilostazol and Aspirin
pp. 87-93(7)
Authors: Mallikaarjun S.; Forbes W.P.; Bramer S.L.